Trial Profile
Randomized comparison of monotherapy (risperidone, quetiapine, or olanzapine) versus combination therapy (risperidone, quetiapine, or olanzapine + divalproex [valproate semisodium]) in the management of dementia with agitation: a pilot comparison of two standard therapies.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2013
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Olanzapine; Quetiapine; Risperidone
- Indications Dementia
- Focus Therapeutic Use
- 17 Nov 2005 New trial record.